Certified Advisory Corp Esperion Therapeutics, Inc. Transaction History

Certified Advisory Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$25.12 - $36.89 $703 - $1,032	-28 Closed	0 $0
Q1 2020 Apr 27, 2020	SELL	$27.44 - $73.84 $686 - $1,846	-25 Reduced 47.17%	28 $1,000
Q2 2019 Aug 07, 2019	BUY	$40.1 - $52.33 $1,002 - $1,308	25 Added 89.29%	53 $2,000
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $1,013 - $2,139	28 New	28 $1,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Certified Advisory Corp with notifications on news.